Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-30

Clinical Trial Update: Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the efficacy of 30% hydrogen peroxide topical application before definitive treatment for skin cancers, including basa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrogen Peroxide 30% topical solution (hydrogen peroxide)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Basal Cell Carcinoma, Squamous Cell Carcinoma of Skin Differentiated | Phase 2 | Status: UNKNOWN